Treatments for severe psoriasis

Australian Prescriber

Volumn 32, Issue 1, 2009, Pages 14-18

  Sullivan, John R ^a   Preda, Veronica A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Adalimumab; Efalizumab; Etanercept; Infliximab; Ustekinumab

Indexed keywords

ADALIMUMAB; ALEFACEPT; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR;

ARTICLE; AUSTRALIA; COMORBIDITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; HEALTH CARE POLICY; HUMAN; LYMPHOCYTE; PHOTOTHERAPY; PSORIASIS; QUALITY OF LIFE; REBOUND;

EID: 65249150200     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2009.006     Document Type: Article

References (8)

1. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008;58:826-50.
2. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
3. Feldman SR, Evans C, Russell MW. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan. J Dermatolog Treat 2005;16:37-42.
4. Stern RS. Psoralen and ultraviolet A light therapy for psoriasis. N Engl J Med 2007;357:682-90.
5. Ortiz Z, Shea B, Suarez Almazor M, Moher D, Wells G, Tugwell P. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD000951. DOI: 10.1002/14651858.CD000951.
6. Katugampola RP Lewis VJ, Finlay AY The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis. Br J Dermatol 2007;156:945-50.
7. Gottlieb AB, Hamilton T, Caro I, Kwon P Compton PG, Leonardi CL; Efalizumab study group. Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial. J Am Acad Dermatol 2006;54 Suppl 1 :S154-63.
8. Lu TY-T, Hill C. Managing patients taking tumour necrosis factor inhibitors. Aust Prescr 2006;29:67-70.